Omnipaque package insert pdf

Omnipaque package insert pdf keyword after analyzing the system lists the list of keywords related and the list of websites with related content, in addition you can see which keywords most interested customers on the this website. An imaging bulk package is used to dispense multiple single doses, utilizing a transfer set cleared for use with this contrast agent in this imaging bulk package. Omnipaque 300 mg iodineml intravenous solution webmd. Use sterile technique for all handling and administration of omnipaque for intravascular, intrathecal, intraarticular, and body cavity administration. Diatrizoate and iodipamide package insert sinografin, squibbus, rev 386. Package is used to dispense multiple single doses, utilizing a suitable transfer device. Imaging bulk package not for intrathecal use rx only. Omnipaque has a neutral taste that even kids will drink. Parenteral administration of omnipaque oral solution 9 and 12. Find patient medical information for omnipaque 300 intravenous on webmd including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Omnipaque 180 be used in children less than 3 months of age. Breeza is the only flavored beverage made with a bitterness blocker to mask the bitter taste of oral iodinated contrast.

Omnipaque 350 omnipaque 350 is not indicated for intrathecal injection, and the indications are clearly defined in the package insert. Omnipaque 350 prescription and dosage sizes information for physicians and healthcare professionals. Orally disintegrating tablets and strips should be left in the package until use. Sterling winthrop corporate quality pharmaceutical file 21089 disclaimer. Omnipaque 350 mg iodineml intravenous solution webmd. Intrathecal administration of omnipaque 140 and omnipaque 350. Consult dantrolene sodium intravenous package insert before using.

Omnipaque is supplied ready to use as clear, colourless to pale yellow, sterile aqueous solutions. Dotarem is a gadoliniumbased contrast agent indicated for intravenous use with magnetic resonance imaging mri in brain intracranial, spine and associated tissues in adult and pediatric patients including term neonates to detect and visualize areas with disruption of the blood brain barrier bbb andor abnormal vascularity. What the pharmacist needs to know presented as a live webinar. Pdf expanding indications for recombinant human tsh in. Iohexol drug monograph pediatric care online aap pointof. Intrathecal administration of corticosteroids with omnipaque. Each package contains a sterile 20mm vialok vented vial access device yukon medical llc, 4021 stirrup creek, durham, nc usa for removal of lc bead lumi from the vial. Acgih guide to occupational exposure values 1991 4. Ensure adequate flushing of the eyes by separating the eyelids with fingers. The recommended dosage of magnevist injection is 0. Sodium chloride 7647145 see package insert section 4. Omnipaque injections by ge healthcare medline industries.

If it is given by injection, a professional will administer it slowly. For procedural contraindications see package insert. Omnipaque 300 is indicated for intrathecal administration in adults including myelography lumbar, thoracic, cervical, total columnar and in. Find patient medical information for omnipaque 350 intravenous on webmd including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Do not immediately repeat myelography because of technical problem see dosing significant bacterial. Extravasation can occur during hand or power injection. Omnipaque 240 iohexol 240 mg iml may be used for intravenous contrast enhanced computed tomography of the head. Extravasation of contrast media frequency the reported incidence of intravenous iv contrast media extravasation related to power injection for ct has ranged from 0. Omnipaque 140 mg iml, 180 mg iml, 210 mg iml, 240 mg iml. Major depressive disorder, obsessive compulsive disorder, bulimia. Omnipaque, oraltag iohexol dosing, indications, interactions. Magnevist injection is indicated for use in mri in adults and pediatric patients 2 years of age and older to facilitate the visualization of lesions with abnormal vascularity in the body. Product monograph omnipaque iohexol injection usp non. On this page about omnipaque350 you will find information relating to side effects, age.

Omnipaque iohexol injection is a radiographic contrast agent indicated for intrathecal, intravascular, oral, rectal, intraarticular and body cavity use. Refer to prescribing information for detailed dosing and administration. Omnipaque iohexol is a nonionic, lowosmolar contrast agent and is also available for oral use, offering gastrointestinal gi visualization with minimal side effects. The frequency of extravasation is not related to the injection flow rate. Omnipaque material safety data sheet cmx medical imaging. Omnipaque iohexol injection 140 180 240 300 350 140 350. Best practices in the use of iodinated contrast media in the clinical setting. Omnipaque contains iohexol, which is equivalent to organic iodine.

If you are allergic hypersensitive to iohexol or any of the other ingredients of omnipaque. Omnipaque 300 is specifically indicated for intrathecal use. Dotarem gadoterate meglumine for use with magnetic. Gadavist gadobutrol injection, for intravenous use initial u. Gadoliniumbased contrast agents gbcas increase the risk for nsf. Omnipaque intrathecal 300 solution for injection nps. Download consumer medicine information leaflet pdf from the therapeutic goods administration tga website. Each vial of lc bead lumi is intended for single patient use only. Nephrogenic systemic fibrosis nsf see full prescribing information for complete boxed warning. This product should not be used in patients with known or.

Patients given contrast mixed with breeza are more likely to comply with full drinking instructions resulting in better initial. Omnipaque oral solution is indicated for oral use only in conjunction with omnipaque injection administered intravenously for computed tomography ct of the abdomen 1. The recommended does for oral use in children is 24mlkg. Check with your doctor to see if you need to drink extra fluids before getting omnipaque iohexol. No liquid is needed to take the orally disintegrating tablet. Immediately flush eyes with plenty of water for at least 15 to 20 minutes. Omnipaque is provided in the following iodine concentrations. Highlights of prescribing information these highlights. Inadvertent intrathecal administration may cause death, convulsions seizures. It is given by injection or orally by a health care professional during or before various imaging tests. After the container closure is punctured, if the integrity of the omnipaque imaging bulk package, the 0. Reviewers comments per diatrizoate and iodipamide mucosal monograph revision of 0888. Inadvertent intrathecal administration may cause death, convulsionsseizures.

To establish an account, call bayer healthcare llcs master distributor. Omnipaque iohexol injection 140 180 240 300 350 140. Omnipaque oral solution 9 and 12 are indicated for oral use only see. Glycopyrrolate occurs as a white, odorless crystalline powder. Tabletwill dissolve rapidly and be swallowed with saliva. On this page about omnipaque300 you will find information relating to side effects, age restrictions, food interactions, whether the medicine is available at a government subsidised price on the pharmaceutical benefits scheme pbs as well as other useful information. Omnipaque at a concentration of 140 mg iml is isotonic to blood. Omnipaque 180 mg iml, 240 mg iml, 300 mg iml, 350 mg iml solution for injection. Use in head and neck area small doses of local anesthetics injected into the head and neck area may produce adverse reactions similar to systemic toxicity seen with unintentional intravascular injections of larger doses. Supporting documents older than three years hespan 6% hetastarch in. Omnipaque package insert pdf keyword found websites. Highlights of prescribing information these highlights do.

The most characteristic effect of intravenous etomidate on the respiratory system is a slight elevation in arterial carbon dioxide tension paco. The estimated total volumes based on this dosage are. It is one of only two iodinated contrast media approved by the u. Omnipaque is provided as a sterile, pyrogenfree, colorless to paleyellow solution, in an imaging bulk package, in the following iodine concentrations. T 3 liothyronine is approximately four times as potent as t 4 levothyroxine on a microgram for microgram. Omnipaque 240 prescription and dosage sizes information for physicians and healthcare professionals. This medicine or fluids is given through a needle or tube catheter inserted into a vein. Omnipaque 350 for gi fluoro water soluble nonionic locm iodinated contrast nonionic unlike gastroview and gastrografin better taste omnipaque 350 350mg iodinecc for gi fluoro diluted omnipaque 240 for peds and omnipaque 240300 for adults po for ct scan. See prescribing information for full boxed warning. Pharmacology, adverse reactions, warnings and side effects. New zealand datasheet 1 product name 2 qualitative and.

These highlights do not include all the information needed. Dailymed omnipaque iohexol injection omnipaque iohexol. Reviewers comments per revision of other radiopaque mucosal agents on 492. Live webinar recorded and archived to be watched at your convenience. Orally administered iohexol is poorly absorbed from the normal gastrointestinal tract. Medscape indicationspecific dosing for omnipaque, oraltag iohexol, frequencybased adverse effects. Food and drug administration fda for myelographic use. New zealand datasheet 1 product name 2 qualitative. Iohexol 300 bulk and 350 bulk are for iv use only and not for intrathecal use. Precautions section of the package insert for symbyax 5. Best practices in the use of iodinated contrast media in. Omnipaque 180, omnipaque 240 or omnipaque 300 may be used in children 3 months of age and older. This information is furnished without warranty, representation, or license of. Food and drug administration 10903 new hampshire avenue silver spring, md 20993 1888infofda 18884636332 contact fda.

1011 543 1059 791 252 484 665 238 1472 1630 14 1123 1117 1577 1146 1046 446 369 547 236 1545 1533 1553 428 1351 271 787 348 284 482 1268 1431 597 65 300 1116 1408 733